[EZ-Cytox] Porous gold nanoparticles for attenuating infectivity of influenza A virus
박지혜
2022-01-25 09:41
2,727
1
-
1790회 연결
본문
년도
2020
제품명
EZ-Cytox
학술지명
JOURNAL OF NANOBIOTECHNOLOGY
Background
Influenza viruses (IVs) have become increasingly resistant to antiviral drugs that target neuraminidase and matrix protein 2 due to gene mutations that alter their drug-binding target protein regions. Consequently, almost all recent IV pandemics have exhibited resistance to commercial antiviral vaccines. To overcome this challenge, an antiviral target is needed that is effective regardless of genetic mutations.
Conclusion
We believe that the technique described herein can be further developed for PoGNP-utilized antiviral protection as well as metal nanoparticle-based therapy to treat viral infection. Additionally, facile detection of IAV can be achieved by developing PoGNP as a multiplatform for detection of the virus.
댓글목록1
박지혜님의 댓글